2,3-Dimethoxy-12-[2-(4-methyl-piperazin-1-yl)-ethyl]-12H-8,10-dioxa-6,12-diaza-cyclopenta[b]chrysen-13-one

ID: ALA195102

PubChem CID: 22139509

Max Phase: Preclinical

Molecular Formula: C26H28N4O5

Molecular Weight: 476.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(=O)n(CCN3CCN(C)CC3)c3c4cc5c(cc4ncc3c2cc1OC)OCO5

Standard InChI:  InChI=1S/C26H28N4O5/c1-28-4-6-29(7-5-28)8-9-30-25-18-12-23-24(35-15-34-23)13-20(18)27-14-19(25)16-10-21(32-2)22(33-3)11-17(16)26(30)31/h10-14H,4-9,15H2,1-3H3

Standard InChI Key:  RUZDATVGHQQGPD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 35 40  0  0  0  0  0  0  0  0999 V2000
   -0.1208   -0.1917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1208    0.6333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8458   -0.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8458    1.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5583    0.6333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5583   -0.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5917    1.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5917    1.8708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3042    0.6333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2708    1.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2708   -0.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1333    2.2833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8458    1.8708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3042    2.2833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5917   -0.6167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0167    1.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0167    1.8708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9833    0.6333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9833   -0.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3042   -1.8542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7375   -2.6917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8458   -1.4292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8042    0.7958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8042    2.1333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2917    1.4583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5917   -1.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0167   -1.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3042   -2.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7375   -1.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0167   -3.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7083   -0.6167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7083    1.0583    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4667   -3.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4208    0.6458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4208   -0.2042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  2  0
  5  6  1  0
  6  3  1  0
  7  2  1  0
  8  7  2  0
  9  7  1  0
 10  5  2  0
 11  6  2  0
 12  8  1  0
 13  4  1  0
 14  8  1  0
 15  1  1  0
 16  9  2  0
 17 16  1  0
 18 19  2  0
 19 11  1  0
 20 26  1  0
 21 30  1  0
 22  3  2  0
 23 16  1  0
 24 17  1  0
 25 23  1  0
 26 15  1  0
 27 20  1  0
 28 20  1  0
 29 27  1  0
 30 28  1  0
 31 19  1  0
 32 18  1  0
 33 21  1  0
 34 32  1  0
 35 31  1  0
  5  4  1  0
 12 13  2  0
 21 29  1  0
 18 10  1  0
 17 14  2  0
 25 24  1  0
M  END

Associated Targets(Human)

RPMI 8402 (281 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB 3-1 (1143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP1 Tclin DNA topoisomerase I (7553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 476.53Molecular Weight (Monoisotopic): 476.2060AlogP: 2.70#Rotatable Bonds: 5
Polar Surface Area: 78.29Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.83CX LogP: 1.93CX LogD: 1.37
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.41Np Likeness Score: -0.60

References

1. Ruchelman AL, Houghton PJ, Zhou N, Liu A, Liu LF, LaVoie EJ..  (2005)  5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.,  48  (3): [PMID:15689163] [10.1021/jm049447z]
2. Zhou W, Dai Z, Chen Y, Yuan Z.  (2013)  Computational QSAR models with high-dimensional descriptor selection improve antitumor activity design of ARC-111 analogues,  22  (1): [10.1007/s00044-012-0034-x]

Source